CLMT vs. DFTX
CLMT (Calumet Specialty Products Partners, L.P.) and DFTX (Definium Therapeutics, Inc) are both stocks. CLMT operates in Oil & Gas E&P (Energy), while DFTX operates in Biotechnology (Healthcare). Over the past year, CLMT returned 159.57% vs 360.48% for DFTX. Their 0.14 correlation means their historical movements had little consistent relationship.
Performance
CLMT vs. DFTX - Performance Comparison
Loading charts...
Returns By Period
In the year-to-date period, CLMT achieves a 102.62% return, which is significantly lower than DFTX's 231.52% return.
CLMT
- 1D
- -3.13%
- 1M
- 9.19%
- 6M
- 64.26%
- YTD
- 102.62%
- 1Y
- 159.57%
- 3Y*
- —
- 5Y*
- —
- 10Y*
- —
- ALL TIME*
- 51.07%
DFTX
- 1D
- 4.89%
- 1M
- 0.14%
- 6M
- 160.66%
- YTD
- 231.52%
- 1Y
- 360.48%
- 3Y*
- 116.90%
- 5Y*
- —
- 10Y*
- —
- ALL TIME*
- 43.03%
Liquidity Comparison
| Position | Avg. Volume Value (2W) | Avg. Volume Value (1M) | Avg. Volume Value (3M) |
|---|---|---|---|
| $46.84M | $48.20M | $36.91M | |
| $69.80M | $81.84M | $102.67M |
CLMT vs. DFTX - Yearly Performance Comparison
| 2026 (YTD) | 2025 | 2024 | |
|---|---|---|---|
CLMT Calumet Specialty Products Partners, L.P. | 102.62% | -9.76% | 28.32% |
DFTX Definium Therapeutics, Inc | 231.52% | 92.39% | -1.97% |
Correlation
The correlation between CLMT and DFTX is 0.08, meaning there was essentially no consistent relationship between their historical price movements. Each responded to its own set of market drivers.
| Correlation | |
|---|---|
Correlation (1Y) Focuses on recent behavior, but can change the most. | 0.08 |
Correlation (All Time) Calculated using the full available price history since Jul 11, 2024 | 0.14 |
Fundamentals
CLMT:
$3.51B
DFTX:
$4.84B
CLMT:
-$2.17
DFTX:
-$2.51
CLMT:
$4.17B
DFTX:
$0.00
CLMT:
$239.60M
DFTX:
$0.00
CLMT:
$67.00M
DFTX:
-$206.36M
Compare stocks, funds, or ETFs
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
Return for Risk
CLMT vs. DFTX — Risk / Return Rank
CLMT
DFTX
CLMT vs. DFTX - Risk-Adjusted Trends Comparison
This table presents a comparison of risk-adjusted performance metrics for Calumet Specialty Products Partners, L.P. (CLMT) and Definium Therapeutics, Inc (DFTX). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.
Values are calculated on a 1-year rolling basis and updated daily. Risk-adjusted metrics are more stable over longer periods — use the period switch above to explore them.
| CLMT | DFTX | Difference | |
|---|---|---|---|
| Sharpe ratioReturn per unit of total volatility | -0.81 | ||
| Sortino ratioReturn per unit of downside risk | -1.06 | ||
| Omega ratioGain probability vs. loss probability | 1.54 | 1.59 | -0.05 |
| Calmar ratioReturn relative to maximum drawdown | 10.69 | 14.66 | -3.96 |
| Martin ratioReturn relative to average drawdown | 28.35 | 44.35 | -16.00 |
Loading charts...
Drawdowns
CLMT vs. DFTX - Drawdown Comparison
The maximum CLMT drawdown since its inception was -61.87%, smaller than the maximum DFTX drawdown of -86.01%. Use the drawdown chart below to compare losses from any high point for CLMT and DFTX.
Loading charts...
Drawdown Indicators
| CLMT | DFTX | Difference | |
|---|---|---|---|
Max DrawdownLargest peak-to-trough decline | -61.87% | -86.01% | +24.14% |
Max Drawdown (1Y)Largest decline over 1 year | -15.01% | -24.79% | +9.78% |
Max Drawdown (3Y)Largest decline over 3 years | — | -58.38% | — |
Current DrawdownCurrent decline from peak | -8.89% | -8.38% | -0.51% |
Average DrawdownAverage peak-to-trough decline | -19.29% | -49.63% | +30.34% |
Ulcer IndexDepth and duration of drawdowns from previous peaks | 5.77% | 8.18% | -2.41% |
Volatility
CLMT vs. DFTX - Volatility Comparison
The current volatility for Calumet Specialty Products Partners, L.P. (CLMT) is 10.85%, while Definium Therapeutics, Inc (DFTX) has a volatility of 17.27%. This indicates that CLMT experiences smaller price fluctuations and is considered to be less risky than DFTX based on this measure. The chart below showcases a comparison of their rolling one-month volatility.
Loading charts...
Volatility by Period
| CLMT | DFTX | Difference | |
|---|---|---|---|
Volatility (1M)Calculated over the trailing 1-month period | 10.85% | 17.27% | -6.42% |
Volatility (6M)Calculated over the trailing 6-month period | 32.39% | 56.79% | -24.40% |
Volatility (1Y)Calculated over the trailing 1-year period | 42.23% | 78.86% | -36.63% |
Volatility (5Y)Calculated over the trailing 5-year period, annualized | 59.79% | 87.02% | -27.23% |
Volatility (10Y)Calculated over the trailing 10-year period, annualized | 59.79% | 87.02% | -27.23% |
Dividends
CLMT vs. DFTX - Dividend Comparison
Neither CLMT nor DFTX has paid dividends to shareholders.
Financials
CLMT vs. DFTX - Financials Comparison
This section allows you to compare key financial metrics between Calumet Specialty Products Partners, L.P. and Definium Therapeutics, Inc. You can select fields from income statements, balance sheets, and cash flow statements to easily visualize and compare the financial health of both companies.
Total Revenue: Total amount of money received from sales and other business activities
Frequently Asked Questions
CLMT and DFTX have a correlation of 0.08, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.
DFTX has higher volatility (17.27%) compared to CLMT (10.85%). In terms of maximum drawdown, CLMT dropped -61.87% vs DFTX's -86.01%.
DFTX currently has the higher Sharpe Ratio (4.61 vs 3.80), meaning it's delivered slightly more return per unit of risk over the trailing 12 months. However, this ranking shifts over time - use the Risk/Return Score above for a more comprehensive view that combines Sharpe, Sortino, and other measures used by quantitative funds.
Find the right allocation for CLMT and DFTX
Add both to a portfolio and optimize allocations for your target — whether that's maximizing returns, minimizing drawdowns, or balancing risk across holdings.
Open Portfolio Optimizer